Related Experiment Video

Updated: Aug 30, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite

Patrick C Walsh

The Journal of Urology

|October 22, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Treatment Response and Outcomes of Prostate Cancer Patients Carrying the Germline MMS22L F722fs Mutation.

The Prostate·2026

Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes.

The Prostate·2025

Germline Testing for Prostate Cancer Patients: Evidence-Based Evaluation of Genes Recommended by NCCN Guidelines.

The Prostate·2025

Discovery of a Recurrent Frameshift Ashkenazi Jewish Founder Mutation (F722fs) in the PARP Inhibitor-sensitive MMS22L Gene Associated with Higher Risk of Prostate Cancer.

European urology focus·2025

Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry.

The Prostate·2022

A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.

European urology·2022

See all related articles